Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$216,190
-$13,612 QoQ
Shares Held
3,752
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,101
of 2,506 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compass Ion Advisors, LLC holds $14,145,503 across 9 Drug Manufacturers - General names. BMY ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,597 | $3,707,199 | |
| 2 | LLY |
ELI LILLY & Co
|
2,130 | $2,554,785 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,384 | $2,233,843 | |
| 4 | ABBV |
AbbVie Inc.
|
8,697 | $2,188,512 | |
| 5 | AMGN |
Amgen Inc
|
5,577 | $2,019,543 | |
| 6 | PFE |
Pfizer Inc
|
25,488 | $613,750 | |
| 7 | NVS |
Novartis AG
|
2,560 | $401,203 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
3,752 | $216,190 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,190 | 3,752 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $229,802 | 3,789 | Shares | Other | 2026-04-13 | |
| 2025-12-31 | $203,030 | 3,764 | Shares | Sole | 2026-01-29 | |
| 2025-03-31 | $229,505 | 3,763 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $210,007 | 3,713 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $186,262 | 4,485 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $243,221 | 4,485 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $230,176 | 4,486 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $276,212 | 4,759 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||